Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One
- PMID: 33965134
- PMCID: PMC8097392
- DOI: 10.1016/j.chest.2020.11.073
Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One
Comment in
-
Response.Chest. 2021 May;159(5):2109-2110. doi: 10.1016/j.chest.2020.12.044. Chest. 2021. PMID: 33965136 Free PMC article. No abstract available.
Comment on
-
Comparative Survival Analysis of Immunomodulatory Therapy for Coronavirus Disease 2019 Cytokine Storm.Chest. 2021 Mar;159(3):933-948. doi: 10.1016/j.chest.2020.09.275. Epub 2020 Oct 17. Chest. 2021. PMID: 33075378 Free PMC article.
References
-
- Tripathi G., Jafar T., Mandal K. Does cytokine gene polymorphism affect steroid responses in idiopathic nephrotic syndrome? Indian J Med Sci. 2008;62(10):383–391. - PubMed
-
- Dittrich A., Khouri C., Sackett S.D. Glucocorticoids increase interleukin-6-dependent gene induction by interfering with the expression of the suppressor of cytokine signaling 3 feedback inhibitor. Hepatology. 2012;55(1):256–266. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
